医思健康2023/24年报

Contents目錄 Awarded two ISO certifications榮獲兩項ISO認證S i g n e d S u s t a i n a b i l i t y - L i n k e dSyndicated Facility訂立可持續發展表現掛鈎銀團貸款 Strategic Collaboration withJiangxi Rimag Group Co., Ltd.與江西一脈陽光集團股份有限公司達成戰略合作 Strategic Collaboration withK e r r yL o g i s t i c s N e t w o r kLimited與嘉里物流聯網有限公司達成戰略合作 Financial Highlights and Five Year Summary財務摘要及五年概要 Financial Highlights and Five Year Summary財務摘要及五年概要 附註： Notes: 1.息稅折舊及攤銷前之盈利等於未計利息、稅項、自有物業、廠房及設備折舊及攤銷前的盈利。息稅折舊及攤銷前之盈利並非香港財務報告準則下的標準計量方法。本公司管理層認為，息稅折舊及攤銷前之盈利作為本集團業務所得經營現金流的代表，為投資者提供有用的補充資料，以評估本集團的表現。 1.EBITDA equals earnings before interests, taxation, depreciation-ownedproperty, plant and equipment and amortisation. EBITDA is not a standardmeasure under HKFRS. The Company’s management believes that EBITDA,as a proxy of operating cash flow generated by the Group’s businesses,provide investors with useful supplementary information to assess theperformance of the Group. 下表載列於所示期間息稅折舊及攤銷前之盈利與除稅前溢利的對賬： The following table sets out the reconciliation of the EBITDA and profit beforetax for the periods indicated: EC Healthcare At A Glance醫思健康一覽 VISION MISSION CORE VALUES IntegrityEmpathyCo-OwnershipDisruptive AgilityExcellence BringHealth,Beauty andHappiness to more People Tobe the leading one-stophealthcare ECOSYSTEM withfocusonpreventiveandprecision medicine Geographical Coverage地域覆蓋 Total of182service points across657,000sq ft covering Greater China (as of Mar 31, 2024)大中華區實現廣泛布局共運營657,000平方呎182個服務點（截至二零二四年三月三十一日） One-Stop, Multi-Brand Ecosystem一站式多品牌生態系統 46diverse brands: luxury and affordable options catering to a wide range of customers46個多元化品牌：為各種客戶提供高端及大眾的選擇 Chairman’s Statement主席報告 Dear Shareholders,各位尊敬的股東： FY24 has been a challenging year for both our company and thehealthcare industry. The slow recovery of the global economy andongoing inflationary pressures continue to suppress consumerdemand. Although geopolitical tensions have eased somewhat,instability in certain regions still affects market sentiment.Additionally, the current high-interest-rate environment, inflationarypressures, and economic uncertainties present unprecedentedchallenges to our business. 二零二四財年對公司及整個醫療保健行業而言，同樣是充滿挑戰的一年。全球經濟復蘇緩慢和持續的通脹壓力繼續抑制消費需求。儘管地緣政治緊張局勢有所緩解，但某些地區的不穩定性仍然影響市場情緒。此外，現行的高息環境、通脹壓力及經濟不確定性為我們的業務帶來了前所未有的挑戰。 香港目前的市場環境複雜多變，面臨諸多挑戰。首先，國際及內地遊客的訪港人數尚未恢復至疫情前水平，消費降級嚴重影響了旅遊業和相關行業的復蘇。同時，香港本地股票市場和房地產市場的波動產生了負面的財富效應，導致本地消費情緒整體下降。香港居民頻繁赴內地和國際旅遊，這進一步分散了本地市場的消費能力，影響了零售和服務業的收入增長。此外，香港勞動人口的下降加劇了招聘難度，延長了招聘周期並推高了成本，給企業的人力資源管理帶來巨大壓力。 The market environment in Hong Kong is particularly complex andvolatile, presenting multiple challenges. Firstly, the number ofinternational and Mainland visitors to Hong Kong has not yet returnedto pre-pandemic levels, and downgraded consumption severelyimpacts the recovery process of tourism and related industries.Meanwhile, fluctuations in the local stock and real estate markets havecreated negative wealth effects, leading to a general decline in localconsumer sentiment. Frequent travel of Hong Kong residents toMainland China and internationally further disperses local marketspending power, affecting revenue growth in the retail and servicesectors. Additionally, the declining labour force in Hong Kong hasexacerbated recruitment difficulties, extended hiring cycles, andincreased costs, posing significant pressures on human resourcesmanagement. Chairman’s Statement主席報告 儘管面臨這些挑戰，政府的一系列經濟刺激措施和我們持續優化的運營策略使我們在今年實現了穩定的業務增長。本集團迅速進行戰略審閱，並採取果斷行動，通過三個關鍵領域推動可持續利潤增長和提升生產力：1）業務發展；2）運營卓越及3）數字化轉型。我們欣然報告，在二零二四財年，我們實現了創歷史新高的收入4,211.0百萬港元，同比增長8.7%。這一成功得益於我們管理層卓越的執行能力和以客戶為中心的方針及有針對性的營銷活動，有效地推動了銷售增長並提升了客戶忠誠度及復購率。 Despite these challenges, a series of government economic stimulusmeasures and our continuous optimization of operational strategieshave enabled us to achieve stable business growth this year. TheGroup conducted a swift strategic review and took decisive actions todrive sustainable profit growth and enhance productivity through threekey areas of focus: 1) business development; 2) operational excellence;and 3) digital transformation. We are pleased to report that weachieved a historical high revenue of HK$4,211.0 million in FY24,representing a 8.7%YoY growth. This success is attributed to ourexcellent management execution and customer-centric approach aswell as targeted marketing campaigns, which have effectively drivensales growth and increased customer loyalty and repeat purchases. 在疫情期間，我們利用有利的租賃市場擴展了業務覆蓋範圍。在二零二四財年，我們著重加速新開設服務點的爬坡過程，以提高其運營效率。我們採取了積極的措施來優化資源分配、加強員工培訓和強化營銷策略，確保新服務點能夠迅速融入市場並實現預期增長。這些新服務點在二零二四財年經歷了爬坡期，逐步克服初期挑戰，顯示出穩步增長的態勢，邁向穩定發展的階段，表明我們的業務運營和市場擴展取得了積極進展。儘管部分新服務點需要較長的爬坡期，但我們相信已經奠定了短期內擴大規模、增強競爭優勢並實現增長的基礎。這一廣泛的網絡使我們能夠為客戶提供更廣泛的醫療保健服務，從而在競爭激烈的市場中取得長遠成功。 During the pandemic, we took advantage of the favourable rentalmarket to expand our business coverage. In FY24, we focused onaccelerating the ramp-up process of newly opened service points toenhance their operational efficiency. We initiated proactive measures tooptimize resou